Sfoglia per RIVISTA
CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII
Collezione AOU Alessandria

  

Items : 1

Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2021 Dec;70(12):3679-3692. doi: 10.1007/s00262-021-03024-0. Epub 2021 Aug

2021
AOU San Luigi di Orbassano
AOU Alessandria

Altosole T; Ferrera F; Astone G; Kalli F; Parodi A; Signori A; Scagliotti G; Guglielmini P; Morales-Barrera R; Carles J; Del Conte G; Aglietta M; Zanardi E; Tomasello L; Nolè F; Fenoglio D; Filaci G; Lamperti G; Criscuolo D; Gianese F; Boccardo F;